UCSF
Radiation Oncology
Dr. Mack Roach III, MD
|
|
Give Review
Mack Roach III is an expert in the field of Radiation Oncology. He went to medical school at Stanford University School of Medicine. Stanford University School of Medicine is a top medical university. Stanford University School of Medicine is ranked 2 in research and 25 in primary care medicine He received awards:"Fellow (FASCO)". Mack Roach III is a published doctor. He published 32 publications, including: 'Re: Genomic Classifier Identifies Men with Adverse Pathology After Radical Prostatectomy Who Benefit from Adjuvant Radiation Therapy.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Re: Genomic Classifier Identifies Men with Adverse Pathology After Radical Prostatectomy Who Benefit from Adjuvant Radiation Therapy.
- Radical Prostatectomy Versus Radiation and Androgen Deprivation Therapy for Clinically Localized Prostate Cancer: How Good Is the Evidence?
- PostProstatectomy Radiotherapy for Patients with High-risk Features on Definitive Pathology: A Plea for Evidence-based Medicine.
- Dose-volume Analysis and the temporal nature of toxicity with stereotactic body radiation therapy for prostate cancer.
- Post-operative Radiation Therapy for Patients at High-risk of Recurrence after Radical Prostatectomy: Does Timing Matter?
- Bladder wall recurrence of prostate Cancer after high-dose-rate brachytherapy.
- Impact of biochemical failure classification on clinical outcome: A secondary Analysis of Radiation Therapy Oncology Group 9202 and 9413.
- Quality improvement of International Classification of Diseases, 9th revision, diagnosis coding in radiation oncology: Single-institution prospective study at Universi...
- High-risk prostate Cancer-classification and therapy.
- Early salvage radiotherapy following radical Prostatectomy.
- Current trends for the use of androgen deprivation therapy in conjunction with radiotherapy for patients with unfavorable intermediate-risk, high-risk, localized, and ...
- Prostate Cancer: Impact of national guidelines on brachytherapy monotherapy.
- Offline multiple adaptive planning strategy for concurrent irradiation of the Prostate and pelvic lymph nodes.
- Role of endorectal MR imaging and MR spectroscopic imaging in defining treatable intraprostatic tumor foci in prostate cancer: Quantitative Analysis of imaging contour...
- Adjuvant and salvage radiation therapy after Prostatectomy: american society for radiation oncology/american urological association guidelines.
- Adjuvant and Salvage Radiotherapy After Prostatectomy: AUA/ASTRO Guideline.
- Salvage HDR Brachytherapy for Recurrent Prostate Cancer After Previous Definitive Radiation Therapy: 5-Year Outcomes.
- Cautious Optimism for Extreme Dose Escalation in Prostate Cancer.
- Overview of randomized controlled treatment trials for clinically localized prostate Cancer: implications for active surveillance and the United States preventative ta...
- Computer-Assisted, Atlas-Based Segmentation for Target Volume Delineation in Whole Pelvic IMRT for Prostate Cancer.
- Urethra low-dose tunnels: Validation of and class solution for generating urethra-sparing dose plans using inverse planning simulated annealing for Prostate high-dose-...
- Long-term potency preservation following brachytherapy for prostate Cancer.
- Management of prostate Cancer patients with lymph node involvement: A rapidly evolving paradigm.
- Feasibility of MR Imaging/MR Spectroscopy-Planned Focal Partial Salvage Permanent Prostate Implant (PPI) for Localized Recurrence After Initial PPI for Prostate Cancer.
- Variation in the definition of clinical target volumes for pelvic nodal conformal radiation therapy for prostate Cancer.
- Pretreatment endoRectal magnetic resonance imaging and magnetic resonance spectroscopic imaging features of prostate cancer as predictors of response to external beam ...
- Multicenter Analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated...
- Endoscopic gold fiducial marker placement into the bladder wall to optimize radiotherapy targeting for bladder-preserving management of muscle-invasive bladder Cancer:...
- Improving plan quality and consistency by standardization of dose constraints in prostate Cancer patients treated with CyberKnife.
- Radical Prostatectomy v radiation: only a randomised trial can provide the answer.
- Hypofractionated SBRT versus conventionally fractionated EBRT for prostate Cancer: comparison of PSA slope and nadir.
Schools
Stanford University School Of Medicine
Ml King Genl Hospital
Ml King Jr Genl Hospital
Highland Genl Hospital
Stanford University
Conditions Treated
- Anal and Rectal Cancer
- Anemia
- Bladder Cancer
- Breast Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Radiation Oncology
Accepted Insurances
Awards
- Fellow (FASCO)
Education
-
Stanford University -
Alameda County Medical Center -
UCSF -
Stanford University School of Medicine
Hospital
-
San Francisco General Hospital and Trauma Center -
San Francisco VA Medical Center -
UCSF Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. Stephen L. Hauser, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leslie C. Moretti, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amy M. Gillis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sue S. Yom, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Theodore L. Phillips, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alexander R. Gottschalk, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Moshiur M. Anwar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Justin M. Linam, MD |
|
|
Dr. Alexei L. Polishchuk, MD
This Doctor is OpenDoctor Recommended.
|